MindWalk Holdings (HYFT) Asset Utilization Ratio (2021 - 2026)
MindWalk Holdings (HYFT) reported Asset Utilization Ratio of 0.17 for Q1 2026, down 25.41% year-over-year from 0.23 in Q1 2025, and up 113.32% quarter-over-quarter from 0.08 in Q4 2025.
MindWalk Holdings (HYFT) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 6 years of Asset Utilization Ratio data on file, last reported at 0.17 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.17, down 25.41% year-over-year; the trailing twelve-month figure through Jan 2026 was 0.17 (down 25.41% YoY), and the FY2025 annual result was 0.0, down 100.0% from the prior year.
- Asset Utilization Ratio grew to 0.17 in Q1 2026 per HYFT's latest filing, from 0.08 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.32 in Q3 2024 and troughed at 0.07 in Q2 2022.
- A 5-year average of 0.19 and a median of 0.21 in 2023 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2025: Asset Utilization Ratio surged 274.64% in 2023, then tumbled 69.36% in 2025.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.19 in 2022, then gained by 17.94% to 0.22 in 2023, then advanced by 17.29% to 0.26 in 2024, then plunged by 69.36% to 0.08 in 2025, then soared by 113.32% to 0.17 in 2026.
- Business Quant data shows HYFT's Asset Utilization Ratio at 0.17 in Q1 2026, 0.08 in Q4 2025, and 0.13 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 0.55 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 0.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 0.17 |
| Oct 31, 2025 | 0.08 |
| Jul 31, 2025 | 0.13 |
| Apr 30, 2025 | 0.12 |
| Jan 31, 2025 | 0.23 |
| Oct 31, 2024 | 0.26 |
| Jul 31, 2024 | 0.32 |
| Apr 30, 2024 | 0.27 |
| Jan 31, 2024 | 0.23 |
| Oct 31, 2023 | 0.22 |
| Jul 31, 2023 | 0.21 |
| Apr 30, 2023 | 0.26 |
| Jan 31, 2023 | 0.25 |
| Oct 31, 2022 | 0.19 |
| Jul 31, 2022 | 0.11 |
| Apr 30, 2022 | 0.07 |
| Jan 31, 2022 | 0.08 |
| Oct 31, 2021 | 0.15 |
| Jul 31, 2021 | 0.21 |